• BioNTech CEO Uğur Şahin disclosed sales of 79,000 ordinary shares on Sept. 21-22, cutting his direct stake to 410,209 shares.
• Transactions were priced at USD 97.81 and USD 100.72 per share, per the filing.
• The filing also listed 39,218,111 ordinary shares held indirectly.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNTech SE published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002123975-26-000021), on September 22, 2026, and is solely responsible for the information contained therein.